Back
Virtus Diversified Income & Convertible Fund Vs. Dyne Therapeutics, Inc. Industry Stock Comparison
Buy
83
ACV
Virtus Diversified Income & Convertible Fund
Last Price:
$26.67
Seasonality Move:
3.3%
Buy
59
DYN
Dyne Therapeutics, Inc.
Last Price:
$20.36
Seasonality Move:
-5.63%
Buy
83
Virtus Diversified Income & Convertible Fund (ACV)
is a Buy
Is Virtus Diversified Income & Convertible Fund a Buy, Sell or Hold?
-
The current Virtus Diversified Income & Convertible Fund [ACV] share price is $26.67. The Score for ACV is 83, which is 66% above its historic median score of 50, and infers lower risk than normal.
-
ACV is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
59
Dyne Therapeutics, Inc. (DYN)
is a Buy
Is Dyne Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Dyne Therapeutics, Inc. [DYN] share price is $20.35. The Score for DYN is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
DYN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ACV Stock Price Chart
What is Virtus Diversified Income & Convertible Fund's stock price today?
-
The Virtus Diversified Income & Convertible Fund share price today is $26.67Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ACV is experiencing buying pressure, which is a positive indicator for future bullish movement.
DYN Stock Price Chart
What is Dyne Therapeutics, Inc.'s stock price today?
-
The Dyne Therapeutics, Inc. share price today is $20.35Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DYN is experiencing selling pressure, which indicates risk of future bearish movement.
ACV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.2 | Buy |
| Relative Strength Index (14 RSI): | 65.84 | Buy |
| Chaikin Money Flow: | 17520 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.18 - 26.3) | Buy |
| Bollinger Bands (100): | (23.31 - 25.73) | Buy |
DYN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.08 | Buy |
| Relative Strength Index (14 RSI): | 52.6 | Buy |
| Chaikin Money Flow: | -514046 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.29 - 21.19) | Buy |
| Bollinger Bands (100): | (12.6 - 20.28) | Buy |
ACV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.9 | Buy |
| 20-day SMA: | 25.97 | Buy |
| 50-day SMA: | 25.51 | Buy |
| 200-day SMA: | 22.88 | Buy |
| 8-day EMA: | 26.09 | Buy |
| 20-day EMA: | 25.9 | Buy |
| 50-day EMA: | 25.44 | Buy |
| 200-day EMA: | 23.67 | Buy |
DYN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 19.75 | Buy |
| 20-day SMA: | 20.08 | Buy |
| 50-day SMA: | 19.92 | Buy |
| 200-day SMA: | 13.56 | Buy |
| 8-day EMA: | 19.99 | Buy |
| 20-day EMA: | 19.95 | Buy |
| 50-day EMA: | 19.06 | Buy |
| 200-day EMA: | 16.72 | Buy |
Virtus Diversified Income & Convertible Fund Earnings Growth & ACV Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Dyne Therapeutics, Inc. Earnings Growth & DYN Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.10 per share, and an increase next year of $0.24 per share.
Virtus Diversified Income & Convertible Fund Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Dyne Therapeutics, Inc. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||